AngioDynamics reported Q3 GAAP net loss of $8.1M, or $0.19 per share, versus a $4.4M loss ($0.11/sh) a year earlier. On a pro forma basis the company reported a $13.1M loss, or $0.31 per share. Results show widened losses year-over-year and are likely to pressure the stock and investor sentiment.
AngioDynamics reported Q3 GAAP net loss of $8.1M, or $0.19 per share, versus a $4.4M loss ($0.11/sh) a year earlier. On a pro forma basis the company reported a $13.1M loss, or $0.31 per share. Results show widened losses year-over-year and are likely to pressure the stock and investor sentiment.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
